David Hyman

David Hyman

Finansdirektör/CFO på MEDICENNA THERAPEUTICS CORP.

Förmögenhet: 27 500 $ per 2026-06-30

Finance
Commercial Services
Consumer Services

Profil

David Hyman is Chief Financial Officer & Secretary at Medicenna Therapeutics Corp.
since 2024.
Former roles include Chief Financial Officer & Secretary at Rakovina Therapeutics, Inc. from 2021 to 2025, Chief Financial Officer & Partner at Tandem Accounting Group Ltd. from 2019 to 2024, Chief Financial Officer at KORT Payments, Inc. from 2016 to 2018, Vice President at Camcor Partners, Inc. from 2008 to 2015, Director at Serafina Energy Ltd., Chief Financial Officer, Secretary & Director at HAW Capital Corp., Vice President at Camcor Capital, Inc., Research Analyst at Raymond James Ltd. (Broker), Senior Manager at Deloitte LLP, Chief Financial Officer at TheraCann International Benchmark Corp., and Chief Financial Officer at Tandem Innovation Group.
Education includes an undergraduate degree from the University of Calgary, conferred in 1995.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-05-28 100 000 ( 0,11 % ) 27 500 $ 2026-06-30

Aktiva positioner av David Hyman

FöretagPositionStart
MEDICENNA THERAPEUTICS CORP. Finansdirektör/CFO 2024-02-14

Tidigare kända positioner av David Hyman

FöretagPositionSlut
RAKOVINA THERAPEUTICS INC. Finansdirektör/CFO 2025-05-01
Finansdirektör/CFO 2024-01-01
Finansdirektör/CFO 2018-07-01
Företagsledare/Principal 2015-08-01
Tandem Innovation Group
Finansdirektör/CFO -
Se detaljerna i David Hymans erfarenhet

David Hymans utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

85

Första gradens relationer

13

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag13

Finance

Finance

Consumer Services

Finance

Commercial Services

Energy Minerals

Commercial Services

Finance

Health Technology

Commercial Services

Commercial Services

Finance

Tandem Innovation Group

  1. Börsen
  2. Insiders
  3. David Hyman